Y. Aydinok

Z. S. Bal, F. Vardar, A. Akıncı, 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Safer and much cheaper circumcision using fibrin glue in severe haemophilia

K. Kavaklı, A. Polat, Y. Aydinok, 1997, Haemophilia : the official journal of the World Federation of Hemophilia.

Prophylactic therapy for hemophilia in a developing country, Turkey.

N. Çetingül, K. Kavaklı, Y. Aydinok, 1997, Pediatric hematology and oncology.

Hematuria in Patients with Congenital Coagulation Factor Deficiencies

K. Kavaklı, C. Balkan, Nihal Karadaş, 2022, Journal of Dr Behcet Uz Children s Hospital.

Observational study comparing long‐term safety and efficacy of Deferasirox with Desferrioxamine therapy in chelation‐naïve children with transfusional iron overload

Y. Oymak, C. Vergin, S. Unal, 2012, European journal of haematology.

Hepatitis C virus and the treatment hemophilia in Turkey

K. Kavaklı, A. Polat, Y. Aydinok, 1998, Transfusion.

Psychosocial implications of Thalassemia Major

S. Erermiş, Y. Aydinok, D. Yılmaz, 2005, Pediatrics international : official journal of the Japan Pediatric Society.

Evaluation of the achievement of hematologists to transfusion medicine education with self-assessment questionnaire in Turkey

Y. Oymak, A. Akıncı, B. Koluman, 2020, Tıp Eğitimi Dünyası.

Zinc concentration in patients with iron overload receiving oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one or desferrioxamine.

A. Hoffbrand, Y. Aydinok, B. Wonke, 1994, Journal of clinical pathology.

A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload.

Vip Viprakasit, Hugh Young Rienhoff, Paul Harmatz, 2012, Blood.

FBS0701, a novel oral iron chelator, in transfusional iron overload A phase 2 study of the safety, tolerability and pharmacodynamics of

E. Neufeld, V. Viprakasit, R. Galanello, 2012 .

HDR (Hypoparathyroidism, Sensorineural Deafness, Renal Dysplasia) Syndrome Presenting with Hypocalcemia-Induced Generalized Psoriasis

S. Aksoylar, Y. Aydinok, M. Coker, 2004, Journal of pediatric endocrinology & metabolism : JPEM.

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia.

S. Perrotta, P. Marks, M. Cappellini, 2006, Blood.

Rare severe mycotic infections in children receiving empirical caspofungin treatment for febrile neutropenia

P. Yazıcı, B. Karapinar, Nihal Karadaş, 2015, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

Proven and probable invasive fungal infections in children with acute lymphoblastic leukaemia: results from an university hospital, 2005–2013

K. Kavaklı, C. Balkan, S. Şen, 2015, Mycoses.

Central Line–Associated Bloodstream Infections in Children With Hematologic and Oncologic Diseases: First Prevalence Results From a University Hospital

Y. Aydinok, Gülçin Özalp Gerçeker, Figen Yardımcı, 2019, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.

Disseminated cryptosporidium infection in an infant with hyper-IgM syndrome caused by CD40 deficiency.

L. Notarangelo, A. Plebani, N. Kutukculer, 2003, The Journal of pediatrics.

Efficacy and Safety of Ruxolitinib in Regularly Transfused Patients with Thalassemia: Results from Single-Arm, Multicenter, Phase 2a Truth Study

E. Cassinerio, A. Taher, N. Hollaender, 2016 .

Amustaline‐glutathione pathogen‐reduced red blood cell concentrates for transfusion‐dependent thalassaemia

A. Piga, N. Huang, R. Benjamin, 2019, British journal of haematology.

Endocrine complications in patients with beta-thalassemia major.

K. Kavaklı, M. Kantar, S. Darcan, 2002, Journal of tropical pediatrics.

Unusual course of an acute lymphoblastic leukemia case with i(9q) as a sole cytogenetic abnormality.

F. Ozkinay, Y. Aydinok, O. Cogulu, 2006, Leukemia research.

Molecular Basis of β-Thalassemia in the Population of the Aegean Region of Turkey: Identification of A Novel Deletion Mutation

C. Vergin, F. Ozkinay, H. Onay, 2015, Hemoglobin.

Beta-thalassemia alleles in Aegean region of Turkey: effect on clinical severity of disease.

N. Çetingül, K. Kavaklı, Y. Aydinok, 1997, Pediatric hematology and oncology.

Serum erythropoietin levels in patients with beta thalassemia major and intermedia.

N. Çetingül, K. Kavaklı, Y. Aydinok, 1997, Pediatric hematology and oncology.

A randomized controlled 1-year study of daily deferiprone plus twice weekly desferrioxamine compared with daily deferiprone monotherapy in patients with thalassemia major

A. Zimmermann, A. Terzi, Z. Ulger, 2007, Haematologica.

Whole-genome sequencing of a sporadic primary immunodeficiency cohort

William J. Astle, Sri V. V. Deevi, Kenneth G. C. Smith, 2020, Nature.

A National Registry of Thalassemia in Turkey: Demographic and Disease Characteristics of Patients, Achievements, and Challenges in Prevention

Y. Oymak, C. Vergin, Y. Kilinç, 2017, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Action plan to regain unnecessary deferred blood donors due to malaria risk in Turkey.

N. Aksoy, K. Gül, Y. Aydinok, 2012, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Tramadol infusion for the pain management in sickle cell disease: a case report

M. Inal, C. Balkan, E. Erhan, 2007, Paediatric anaesthesia.

Recommendations for Pregnancy in Rare Inherited Anemias

H. Tamary, A. Iolascon, R. Russo, 2020, HemaSphere.

Investigation of West Nile virus among healthy blood donors in the western part of Turkey.

Y. Aydinok, E. Karataylı, A. M. Bozdayi, 2015, Turkish journal of medical sciences.

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with -thalassemia

M. Cappellini, A. Piga, M. Bejaoui, 2006 .

Intense myelofibrosis in a child: unusual result of EBV-associated hemophagocytic lymphohistiocytosis.

K. Kavaklı, B. Karapinar, E. Türkoğlu, 2007, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Multi-center transferability of a breath-hold T2 technique for myocardial iron assessment

D. Pennell, M. Fogel, D. Firmin, 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

A further Turkish case of Griscelli syndrome with new RAB27A mutation.

C. Balkan, F. Ozkinay, H. Onay, 2008, Journal of the American Academy of Dermatology.

A severe alpha thalassemia case compound heterozygous for Hb Adana in alpha1 gene and 20.5 kb double gene deletion.

F. Ozkinay, H. Onay, Y. Aydinok, 2009, Journal of pediatric hematology/oncology.

Diverse phenotypic and genotypic presentation of RAG1 mutations in two cases with SCID

N. Kutukculer, G. Aksu, N. Gulez, 2009, Clinical and Experimental Medicine.

HAX1 mutation positive children presenting with haemophagocytic lymphohistiocytosis

Y. Oymak, C. Vergin, F. Hazan, 2017, British journal of haematology.

Unusual presentation of brucellosis in a child: Acute blindness

B. Karapinar, F. Vardar, Y. Aydinok, 2005, Acta paediatrica.

Two male siblings with a novel LRBA mutation presenting with different findings of IPEX syndrome

E. Gambineri, N. Kutukculer, G. Aksu, 2018, JMM case reports.

Highlights on the Luspatercept Treatment in Thalassemia

Y. Aydinok, 2023, Thalassemia Reports.

Neuropsychologic sequelae in the long-term survivors of childhood acute lymphoblastic leukemia.

N. Çetingül, K. Kavaklı, N. Çelebisoy, 1999, Pediatric hematology and oncology.

Leukapheresis in Childhood Acute Leukemias: Single-Center Experience

K. Kavaklı, C. Balkan, P. Yazıcı, 2014, Pediatric hematology and oncology.

Severe aplastic anemia following liver transplantation in a patient with non-A-E fulminant hepatitis.

B. Karapinar, S. Aydoğdu, Y. Aydinok, 2011, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

Myelofibrosis in a child with EBV‐associated Hemophagocytic Lymphohistiocytosis

Y. Aydinok, 2008, Pediatric blood & cancer.

Current childhood chronic myeloid leukemia management under tyrosine kinase inhibitor treatment

K. Kavaklı, C. Balkan, Nihal Karadaş, 2022, International Journal of Hematology.

Stevens-Johnson Syndrome associated with methotrexate treatment for acute lymphoblastic leukemia: a case report.

K. Kavaklı, C. Balkan, Y. Aydinok, 2018, Archivos argentinos de pediatria.

The Effect of HFE Polymorphisms on Cardiac Iron Overload in Patients with Beta-Thalassemia Major

Y. Oymak, C. Vergin, T. Meşe, 2013, Pediatric hematology and oncology.

Plasma Platelet-activating Factor (PAF) Levels and Desmopressin Response in Children with Hemophilia A and von Willebrand's Disease

K. Kavaklı, A. Polat, Y. Aydinok, 1999, Thrombosis and Haemostasis.

Myocardial Iron Loading in Patients With Thalassemia Major in Turkey and the Potential Role of Splenectomy in Myocardial Siderosis

H. Alper, S. Bayraktaroğlu, Y. Aydinok, 2011, Journal of pediatric hematology/oncology.

Efficacy and Safety of Deferasirox (Exjade®) in Preventing Cardiac Iron Overload in β-Thalassemia Patients with Normal Baseline Cardiac Iron: Results from the Cardiac Substudy of the EPIC Trial

D. Pennell, A. Taher, A. El‐Beshlawy, 2008 .

Efficacy and Safety of Deferasirox (Exjade®) in Reducing Cardiac Iron in Patients with β-Thalassemia Major: Results from the Cardiac Substudy of the EPIC Trial

D. Pennell, M. Cappellini, Chi-kong Li, 2008 .

Efficacy and Safety of Deferasirox (Exjade®) with up to 4.5 Years of Treatment in Patients with Thalassemia Major: A Pooled Analysis

M. Cappellini, R. Galanello, A. Piga, 2008 .

Deferasirox (Exjade®) in Pediatric Patients with β-Thalassemia: Update of 4.7-Year Efficacy and Safety from Extension Studies

R. Galanello, A. Piga, G. Forni, 2008 .

Safety, Tolerability and Dose Response of FBS0701, a Novel Iron Chelator for Treatment of Transfusional Iron Overload: Results of a 24-Week Multicenter, International Phase 2 Study

E. Neufeld, H. Rienhoff, E. Vichinsky, 2011 .

An open‐label, multicenter, efficacy, and safety study of deferasirox in iron‐overloaded patients with non‐transfusion‐dependent thalassemia (THETIS): 5‐year results

M. Cappellini, V. Viprakasit, A. Taher, 2022, American journal of hematology.

Deferasirox Compared With Deferoxamine For The Removal Of Cardiac Iron In Patients With β-Thalassemia Major: 2-Year Data From The Cordelia Extension

D. Pennell, A. Piga, A. El‐Beshlawy, 2013 .

The effect of reducing repetition time TR on the measurement of liver R2 for the purpose of measuring liver iron concentration

A. El‐Beshlawy, A. Ibrahim, M. Hamdy, 2011, Magnetic resonance in medicine.

EFFICACY AND SAFETY OF DEFERASIROX IN PATIENTS WITH BASELINE LIVER IRON CONCENTRATION (LIC) < 7 OR=7 MG FE/G DW: RESULTS OF EPIC LIVER MAGNETIC RESONANCE IMAGING (MRI) SUBSTUDY

A. Taher, A. El‐Beshlawy, Mohsen Saleh Elalfy, 2010 .

Continued Improvement and Normalization of Myocardial T2* In Patients with β-thalassemia Major Treated with Deferasirox (Exjade®) for up to 3 Years

D. Pennell, M. Cappellini, Chi-kong Li, 2010 .

Timed non-transferrin bound iron determinations probe the origin of chelatable iron pools during deferiprone regimens and predict chelation response

J. Porter, Y. Aydinok, P. Evans, 2012, Haematologica.

CONTINUED IMPROVEMENT IN CARDIAC T2*WITH DEFERASIROX TREATMENT OVER 2 YEARS: RESULTS FROM THE EXTENSION OF EPIC CARDIAC SUBSTUDY IN BETA-THALASSAEMIA PATIENTS WITH MYOCARDIAL SIDEROSIS

D. Pennell, M. Cappellini, Chi-kong Li, 2010 .

Efficacy and Safety of Deferasirox (Exjade®) in β-Thalassemia Patients with Myocardial Siderosis: 2-Year Results From the EPIC Cardiac Sub-Study.

D. Pennell, M. Cappellini, Chi-kong Li, 2009 .

Efficacy and safety of deferasirox (Exjade®) in patients with β-thalassemia major treated for up to 5 years

S. Perrotta, M. Cappellini, A. Piga, 2009 .

The relationship between the myocardial T2* value and left ventricular volumetric and functional parameters in thalassemia major patients.

H. Alper, S. Bayraktaroğlu, R. Savaş, 2011, Diagnostic and interventional radiology.

Successful desensitization of a case with desferrioxamine hypersensitivity.

D. Can, R. Tanaç, F. Gülen, 2006, Minerva pediatrica.

Fertility in Patients with Thalassemia and Outcome of Pregnancies: A Turkish Experience

K. Kavaklı, C. Balkan, Y. Aydinok, 2019, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Stiffness of the Abdominal Aorta in β-Thalassemia Major Patients Related With Body Iron Load

Z. Ulger, E. Levent, Y. Aydinok, 2006, Journal of pediatric hematology/oncology.

Insulin secretion-sensitivity index-2 could be a novel marker in the identification of the role of pancreatic iron deposition on beta-cell function in thalassemia major.

Nihal Karadaş, S. Bayraktaroğlu, Y. Aydinok, 2019, Endocrine journal.

Prevalence of beta-thalassaemia trait in 1124 students from Aegean region of Turkey.

K. Kavaklı, Y. Aydinok, G. Nişli, 1997, Journal of tropical pediatrics.

Urinary zinc excretion and zinc status of patients with beta-thalassemia major.

N. Çetingül, K. Kavaklı, M. Kantar, 1999, Biological Trace Element Research.

Persistent elevated serum levels of intact parathyroid hormone after reoperation for primary hyperparathyroidism and after pamidronate therapy.

S. Darcan, D. Gökşen, Y. Aydinok, 2003, The Turkish journal of pediatrics.

Triosephosphate isomerase deficiency: a patient with Val231Met mutation.

S. Yılmaz, E. Ozer, L. Manco, 2011, Pediatric Neurology.

Ddavp treatment in children with haemophilia b

K. Kavaklı, Y. Aydinok, D. Karapınar, 2001, British journal of haematology.

Is Monitoring of Cytomegalovirus Disease Required in Nontransplant Pediatric Acute Lymphoblastic Leukemia?

C. Balkan, Z. S. Bal, S. Şen, 2021, Journal of pediatric hematology/oncology.

Examination of echocardiographic parameters for the early diagnosis of cardiac dysfunction in beta thalassemia major patients

Y. Oymak, C. Vergin, T. Meşe, 2014 .

P1505: USING ARTIFICIAL INTELLIGENCE NEURAL NETWORKS TO OBTAIN AUTOMATED LIVER IRON CONCENTRATION MEASUREMENTS USING MAGNETIC RESONANCE IMAGING – A MULTI-SCANNER VALIDATION STUDY

S. Bangma, S. Bayraktaroğlu, Y. Aydinok, 2022, HemaSphere.

Molecular analysis of abnormal hemoglobins in beta chain in Aegean region of Turkey and first reports of hemoglobin Andrew-Minneapolis and Hb Hinsdale from Turkey

C. Vergin, H. Onay, Y. Aydinok, 2015, Hematology.

Urinary zinc excretion and zinc status of patients with Β-thalassemia major

N. Çetingül, K. Kavaklı, M. Kantar, 1999, Biological Trace Element Research.

[Bacterial contamination in blood and blood products].

S. Aydemir, Y. Aydinok, A. Tünger, 2005, Mikrobiyoloji bulteni.

Evaluation of the effects of and earliest response rate to anti-D treatment in children with chronic idiopathic thrombocytopenic purpura: a pilot study.

B. Tunç, L. Olcay, S. Yetgin, 2010, Turkish Journal of Pediatrics.

Acquired Hemophilia in Pediatric Population.

N. Çetingül, K. Kavaklı, Y. Aydinok, 2002, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Safety and pharmacokinetics of the oral iron chelator SP‐420 in β‐thalassemia

E. Neufeld, V. Viprakasit, A. Taher, 2017, American journal of hematology.

Invasive Fungal Infections in Children With Acute Myeloid Leukemia: A Single-center Experience Over 19 Years

Z. S. Bal, Nihal Karadaş, Y. Aydinok, 2023, Journal of pediatric hematology/oncology.

Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia.

D. Pennell, M. Cappellini, Chi-kong Li, 2010, Blood.

Rabbit Antithymocyte Globulin Treatment in Childhood Acquired Severe Aplastic Anemia

K. Kavaklı, C. Balkan, Nihal Karadaş, 2014, Pediatric hematology and oncology.

ACE-536 Increases Hemoglobin and Decreases Transfusion Burden and Serum Ferritin in Adults with Beta-Thalassemia: Preliminary Results from a Phase 2 Study

S. Perrotta, A. Piga, V. Caruso, 2014 .

Time domain heart rate variability analysis in patients with thalassaemia major

Z. Ulger, E. Levent, Y. Aydinok, 2005, Acta cardiologica.